Polycystic kidney disease
MONDO:0020642A usually autosomal dominant and less frequently autosomal recessive genetic disorder characterized by the presence of numerous cysts in the kidneys leading to end-stage renal failure. The autosomal dominant trait is associated with abnormalities on the short arm of chromosome 16. Symptoms in patients with the autosomal dominant trait usually appear at middle age and include abdominal pain, hematuria, and high blood pressure. Patients may develop brain aneurysms and liver cysts. Patients with the autosomal recessive trait present with progressive renal failure early in life and symptoms resulting from hepatic fibrosis. The autosomal recessive trait is associated with abnormalities of chromosome 6. Polycystic kidney disease may also result as a side effect in patients on renal dialysis.
Also known as: PKD - polycystic kidney disease, fibrocystic renal disease, polycystic kidney disease
71 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Can a Low-Carb diet calm kidney disease inflammation?
Disease control Not yet recruitingThis study tests whether a low-carbohydrate, plant-based diet can lower inflammation in people with autosomal dominant polycystic kidney disease (ADPKD). Thirty-six adults will try the special diet and their usual diet in random order, each for 12 weeks. The main goal is to see i…
Phase: NA • Sponsor: Assaf-Harofeh Medical Center • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Could a common cholesterol pill be the key to slowing a deadly kidney disease?
Disease control Not yet recruitingThis study tests whether bempedoic acid, a drug already approved for high cholesterol, can safely slow the progression of autosomal dominant polycystic kidney disease (ADPKD). About 120 adults with rapidly progressing ADPKD will receive either the drug or a placebo for two years.…
Phase: PHASE2 • Sponsor: Kenneth Hallows • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Dietary intervention aims to slow kidney cyst progression
Disease control Not yet recruitingThis study tests whether a 12-month diet low in salt, caffeine, protein, and carbs, but high in potassium and water, can slow kidney cyst growth in 30 adults with ADPKD. Participants are split into diet and regular diet groups. The goal is to see if the diet reduces cyst progress…
Phase: NA • Sponsor: Loma Linda University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Thyroid hormones may hold clues to kidney disease progression
Knowledge-focused Not yet recruitingThis observational study will measure thyroid hormone levels in stored blood and urine samples from 51 people with severe chronic kidney disease (stages 4 and 5). Researchers aim to understand how these hormones differ in patients with and without polycystic kidney disease. The s…
Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
New drug interaction study launches for polycystic kidney disease treatment
Knowledge-focused Not yet recruitingThis early-stage study tests how a new drug called JMKX003142 interacts with other common medications in 112 healthy Chinese adults. The drug is being developed for autosomal dominant polycystic kidney disease (ADPKD). Researchers will measure how the body processes JMKX003142 wh…
Phase: PHASE1 • Sponsor: Jemincare • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
ER study aims to uncover hidden kidney problems in kids
Knowledge-focused Not yet recruitingThis study will observe 50 children (ages 1 month to 18 years) who come to the emergency room with kidney-related symptoms like swelling, blood in urine, or high blood pressure. Researchers want to learn which kidney diseases are most common and how children respond to initial tr…
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New Drug's heart effects under microscope in early safety trial
Knowledge-focused Not yet recruitingThis early-stage study checks whether a single dose of JMKX003142 affects the heart's electrical activity in 24 healthy Chinese adults. Participants will be randomly assigned to receive the drug or a placebo. The goal is to see if the drug causes any changes in heart rhythm, not …
Phase: PHASE1 • Sponsor: Jemincare • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Healthy men to help unravel how new kidney drug is processed
Knowledge-focused Not yet recruitingThis phase 1 trial will enroll 8 healthy Chinese men to study how the experimental drug JMKX003142 is absorbed, broken down, and eliminated from the body. Participants will receive the drug in both pill and IV forms, some with a radioactive tracer. The study aims to measure the d…
Phase: PHASE1 • Sponsor: Jemincare • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
30,000 blood samples could revolutionize rapid disease testing
Knowledge-focused Not yet recruitingThis study will collect blood samples from 30,000 adults in the UK with various health conditions, including blood clots, infections, heart disease, diabetes, and more. The samples will be used to develop and fine-tune new diagnostic tests for the cobas® lumira device, which allo…
Sponsor: LumiraDx UK Limited • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
New kidney drug interaction study launches in healthy volunteers
Knowledge-focused Not yet recruitingThis early-stage study tests how a new drug called JMKX003142 interacts with two common medications—amiodarone (for heart rhythm) and febuxostat (for gout)—in 48 healthy Chinese adults. Participants will take the drugs in sequence to measure how their bodies process them. The goa…
Phase: PHASE1 • Sponsor: Jemincare • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:26 UTC